-
1
-
-
0242659142
-
Attributable mortality of nosocomial candidemia, revisited
-
Gudlaugsson O, Gillespie S, Lee K, et al: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37:1172-1177
-
(2003)
Clin Infect Dis
, vol.37
, pp. 1172-1177
-
-
Gudlaugsson, O.1
Gillespie, S.2
Lee, K.3
-
2
-
-
0035870646
-
Prophylactic antifungal therapy in the intensive care unit
-
Rex JH, Sobel JD: Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 2001; 32:1191-1200
-
(2001)
Clin Infect Dis
, vol.32
, pp. 1191-1200
-
-
Rex, J.H.1
Sobel, J.D.2
-
3
-
-
12844257414
-
Clinical trials of antifungal prophylaxis among patients in surgical intensive care units: Concepts and considerations
-
Lipsett PA: Clinical trials of antifungal prophylaxis among patients in surgical intensive care units: Concepts and considerations. Clin Infect Dis 2004; 39:S193-S199
-
(2004)
Clin Infect Dis
, vol.39
-
-
Lipsett, P.A.1
-
4
-
-
8744260562
-
Prophylaxis and treatment of invasive candidiasis in the intensive care setting
-
Ostrosky-Zeichner L: Prophylaxis and treatment of invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2004; 23:739-744
-
(2004)
Eur J Clin Microbiol Infect Dis
, vol.23
, pp. 739-744
-
-
Ostrosky-Zeichner, L.1
-
5
-
-
0035080325
-
Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients
-
Pelz RK, Hendrix CW, Swoboda SM, et al: Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001; 233:542-548
-
(2001)
Ann Surg
, vol.233
, pp. 542-548
-
-
Pelz, R.K.1
Hendrix, C.W.2
Swoboda, S.M.3
-
6
-
-
0033047638
-
Fluconazole prophylaxis prevents intraabdominal candidiasis in high-risk surgical patients
-
Eggimann P, Francioli P, Bille J, et al: Fluconazole prophylaxis prevents intraabdominal candidiasis in high-risk surgical patients. Crit Care Med 1999; 27:1066-1072
-
(1999)
Crit Care Med
, vol.27
, pp. 1066-1072
-
-
Eggimann, P.1
Francioli, P.2
Bille, J.3
-
7
-
-
33645833237
-
Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials
-
Vardakas KZ, Samonis G, Michalopoulos A, et al: Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials. Crit Care Med 2006; 34:1216-1224
-
(2006)
Crit Care Med
, vol.34
, pp. 1216-1224
-
-
Vardakas, K.Z.1
Samonis, G.2
Michalopoulos, A.3
-
8
-
-
0036453937
-
Prevention of severe Candida infections in non-neutropenic, high- Risk, critically ill patients: A randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination
-
Garbino J, Lew DP, Romand JA, et al: Prevention of severe Candida infections in non-neutropenic, high- risk, critically ill patients: A randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002; 28:1708-1717
-
(2002)
Intensive Care Med
, vol.28
, pp. 1708-1717
-
-
Garbino, J.1
Lew, D.P.2
Romand, J.A.3
-
9
-
-
0141433193
-
Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: A prospective, randomized, double-blind study
-
Sharpe MD, Ghent C, Grant D, et al: Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: A prospective, randomized, double-blind study. Transplantation 2003; 76:977-983
-
(2003)
Transplantation
, vol.76
, pp. 977-983
-
-
Sharpe, M.D.1
Ghent, C.2
Grant, D.3
-
10
-
-
0032758271
-
Prophylactic fluconazole in liver transplant recipients: A randomized, double-blind, placebo-controlled trial
-
Winston DJ, Pakrasi A, Busuttil RW: Prophylactic fluconazole in liver transplant recipients: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131:729-737
-
(1999)
Ann Intern Med
, vol.131
, pp. 729-737
-
-
Winston, D.J.1
Pakrasi, A.2
Busuttil, R.W.3
-
11
-
-
0023113443
-
Ketoconazole prevents Candida sepsis in critically ill surgical patients
-
Slotman GJ, Burchard KW: Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg 1987; 122:147-151
-
(1987)
Arch Surg
, vol.122
, pp. 147-151
-
-
Slotman, G.J.1
Burchard, K.W.2
-
12
-
-
0036720774
-
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999
-
Trick WE, Fridkin SK, Edwards JR, et al: Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002; 35:627-630
-
(2002)
Clin Infect Dis
, vol.35
, pp. 627-630
-
-
Trick, W.E.1
Fridkin, S.K.2
Edwards, J.R.3
-
13
-
-
0037137576
-
Comparison of caspofungin and amphotericin B for invasive candidiasis
-
Caspofungin Invasive Candidiasis Study Group
-
Mora-Duarte J, Betts R, Rotstein R, et al: Caspofungin Invasive Candidiasis Study Group. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347:2020-2029
-
(2002)
N Engl J Med
, vol.347
, pp. 2020-2029
-
-
Mora-Duarte, J.1
Betts, R.2
Rotstein, R.3
-
14
-
-
1642420267
-
Caspofungin resistance in Candida albicans: Correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis
-
Hernandez S, Lopez-Ribot JL, Najvar LK, et al: Caspofungin resistance in Candida albicans: Correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis. Antimicrob Agents Chemother 2004; 48: 1382-1383
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 1382-1383
-
-
Hernandez, S.1
Lopez-Ribot, J.L.2
Najvar, L.K.3
-
15
-
-
19044386459
-
Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate
-
Goodman D, Pamer E, Jakubowski A, et al: Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Clin Infect Dis 2002; 35: E35-E36
-
(2002)
Clin Infect Dis
, vol.35
-
-
Goodman, D.1
Pamer, E.2
Jakubowski, A.3
|